T
Tensive
Biotech & Life Sciences · Milan, Italy · Founded 2012
Develops innovative prostheses aiming to substitute silicone implants MoreLess
Developer of vascularize biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's prostheses are porously implantable based on biodegradable synthetic biomaterials and fabricated with internal micro-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling patients to improve their quality of life and avoid recurrent and expensive surgical operations. Keywords: Healthcare Devices, Services, Supplies, Biodegradable Prosthesis, Breast Reconstruction Technique, Breast Restoration, Breast Treatment, Prosthetic Breast Reconstruction, Synthetic Biomaterials.
Company overview
Tensive company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2012
- Headquarters
- Milan, Italy
- Employees
- 31
- Open positions
- 2
- Dealroom signal
- 80.3
Valuation & funding
Tensive funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Sep 2026 | $22M | — | European Investment Bank | ↗ |
| SERIES A✓Equity / VC | Jan 2025 | $15M | $62M | Panakès Partners · EIC Fund | ↗ |
| GRANT✓Other financing | Oct 2022 | $2.5M | — | European Innovation Council | — |
| EARLY VC✓Equity / VC | Oct 2022 | $0 | — | EIC Fund | — |
| GRANT✓Other financing | Jun 2018 | $3M | — | European Innovation Council | ↗ |
| GRANT✓Other financing | Jun 2016 | European Innovation Council | — | ||
| CONVERTIBLE✓Equity / VC | May 2016 | CDP Venture Capital | ↗ | ||
| SEED✓Equity / VC | Jan 2016 | Rancilio Cube | — | ||
| SPINOUT✓Other financing | Jan 2012 | Fondazione UNIMI · University of Milan | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | Profit | Margin |
|---|---|---|---|---|
| 2026 | $1.5M | 0% | −$2.8M | -184.1% |
| 2025 | $1.5M | 0% | −$2.8M | -184.1% |
| 2024 | $1.5M | +7.1% | −$2.8M | -184.1% |
| 2023 | $1.4M | +274.3% | ||
| 2022 | $384K | -35.3% | ||
| 2021 | $593K | -27.4% | ||
| 2020 | $817K | — |
Growth signals
Tensive website traffic
Latest recorded traffic for Tensive is 290 monthly website visits, down 55.4% over the last three months. Tensive's team declined 16.2% over the past year.
Hiring
Open positions at Tensive
Current openings linked to this company in Dealroom.
Comparisons
Tensive compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Tensive's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Tensive has talent and traffic
team presence
In the news
Latest news about Tensive
Recent press, funding announcements, and product moves mentioning Tensive — open to read from the original sources.
Market sentiment
What the market is saying about Tensive
An AI-synthesized read of the highest-engagement posts about Tensive on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tensive’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.